期刊文献+

血脂康对老年冠心病合并血脂异常患者的调脂疗效 被引量:2

To probe the curative effect of xuezikan cape on the elder patients with coronary heart disease combined by dyslipoproteinemia
下载PDF
导出
摘要 目的观察老年人冠心病合并血脂异常患者口服血脂康胶囊降脂作用的临床疗效。方法56例诊断为冠心病合并血脂异常的老年患者,随机分成两组,对照纽和治疗纽,每纽28例。两组患者均排除糖尿病,肾病综合征,药物等继发性血脂异常;均采用消心痛注射液+5%葡萄糖注射液250ml静脉滴注,2次/d,10%氯化钾7ml、普通胰岛素3U+5%葡萄糖注射液250ml静脉滴注,1次/d,连续14d为1疗程。间隔7d后,再行第2疗程,共3个疗程。治疗组加服血脂康胶囊2粒/次,2次/d,连服8周。结果治疗组LDL—c,TC,TG明显降低,升高HDL-c(P〈0.01),差异有统计学意义。结论血脂康有明显的调脂作用。 Objective To observe the clinic effect on the elder patients with coronary heart disease by take Xuezikang cape orally. Methods 56 patients with coronary heart disease combined by dyslipoproteinemia divide into two groups:control group and treatment group trabant and each group is 28 patients. Each patient take injection vascardin+5% injection glycose 250ml, iv gtt, bid; 10% KCl 7ml, RI 3U+5%injection glycose 250ml iv gtt, qd, successive14 days is one course of treatment .Each patient increase Xue Zi Kang Capsule 2 capsule/vices bid in the treatment group after interval 7d, successive 8 weeks. Results Xue Zi Kang Capsule degrade obviously LDL-c, TC, TG, andheighten HDh-c(P〈0. 01).Conclusion Xue Zi Kang Capsule obviously adjust blood fat ,safely and reliably.
作者 熊春霖
机构地区 中山市横栏医院
出处 《国际医药卫生导报》 2008年第16期30-32,共3页 International Medicine and Health Guidance News
关键词 冠心病 血脂异常 血脂康 Coronary Heart Disease Dyslipoproteinemia Xue Zi Kang Capsule
  • 相关文献

参考文献6

二级参考文献29

  • 1李莹,王抒,陈文祥,徐晨,吕敏,李健斋.多中心临床试验研究中血脂测定室间质量控制[J].中华检验医学杂志,2004,27(10):656-659. 被引量:5
  • 2李炜弘,王米渠,王刚,刘江涛.冠心病心阳虚证相关差异表达基因分析[J].现代中西医结合杂志,2004,13(24):3219-3222. 被引量:17
  • 3刘彬.冠心病家族史阳性儿童血脂研究[J].中国冶金工业医学杂志,2002,19(3):138-139. 被引量:1
  • 4Eisenmann JC, Wrede J, Heelan KA. Associations between adiposity, family history of CHD and blood pressure in 3-8 yearold children [J]. J Hum Hypertens,2005,12(5) : 19 - 23
  • 5陈聪,张天娥,李炜弘,等.一对冠心病血瘀证双生子的家系研究[J].信息与中医药论丛.新加坡医药卫生出版社,2004,165
  • 6陈维养主编.血瘀证诊断标准和传统活血化瘀药范围的研究.陈可翼医学选集[M].北京:北京大学医学出版社,2002,304-307
  • 7Mukherjee M, Desai BH.Platelet adhesiveness in coronary heart disease[J]. Indian Heart J, 1993,45(3) : 195 - 198
  • 8Tse HF, Thambar S, Kwong YL, et al. Safety of catheterbased intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol, 2006,98( 1 ) :60-62.
  • 9Schumacher B, yon Specht BU, Haberstioh J, et al. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF. J Cardiovasc Surg (Trino),1998,39(4) :445-453.
  • 10Schumacher B, Peeher P, yon Specht BU, et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation, 1998,97 ( 7 ) :645-650.

共引文献3364

同被引文献36

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部